Cancer rates are genuinely rising, not just in perception. Nearly 2 million new cancer cases were projected in the United States for 2023 alone, and globally, the World Health Organization estimates a 77% increase in new cases by 2050 compared to 2022. But the reasons aren’t mysterious or singular. A combination of lifestyle shifts, environmental exposures, an aging population, and better detection are all pushing the numbers up at the same time.
The Numbers Are Real, Not Just a Feeling
The sense that cancer is everywhere isn’t paranoia. In the U.S., about 1,958,310 new cancer cases were projected for 2023, alongside 609,820 deaths. Prostate cancer alone reversed two decades of decline, climbing 3% per year from 2014 through 2019, which translates to roughly 99,000 additional diagnoses. Globally, the WHO predicts over 35 million new cases annually by 2050, up from about 20 million in 2022.
Some of this growth simply reflects the fact that more people are alive and living longer. Cancer is fundamentally a disease of accumulated cellular damage, so as populations age, more people reach the years when cancer becomes likely. But aging doesn’t explain the whole picture, because one of the most alarming trends is cancer striking younger people.
Cancer Is Showing Up Earlier in Life
Between 2010 and 2019, incidence rates for 14 different cancer types increased among Americans under 50. The largest jump was in breast cancer among younger women, with roughly 4,800 more cases in 2019 than expected based on 2010 rates. Colorectal cancer added about 2,100 extra cases in that age group, followed by kidney (1,800), uterine (1,200), and pancreatic cancers (500).
Colorectal cancer tells the story most starkly. In 1995, only 11% of colorectal cancer diagnoses were in people under 55. By 2019, that share had doubled to 20%. These younger cases also tend to be diagnosed at more advanced stages and in the left side of the colon or rectum, which suggests they aren’t being caught early by screening. The overall decline in colorectal cancer rates slowed from 3% to 4% annually in the 2000s to just 1% annually from 2011 to 2019, largely because gains in older adults were being offset by rising rates in younger ones.
This shift is why the recommended age for colorectal cancer screening dropped from 50 to 45 in recent years. But the trend itself points to something in the environment or lifestyle of people born after 1960 that older generations weren’t exposed to at the same level.
Obesity Now Drives 40% of U.S. Cancer Diagnoses
Excess body weight is linked to 13 types of cancer, and together those cancers account for 40% of all diagnoses in the United States each year. In 2022 alone, more than 716,000 obesity-associated cancers occurred in the U.S. The list includes some of the most common cancers: breast (postmenopausal), colorectal, uterine, kidney, liver, pancreatic, ovarian, thyroid, gallbladder, upper stomach, esophageal, a type of brain cancer called meningioma, and the blood cancer multiple myeloma.
Women bear a disproportionate burden, accounting for about 495,000 of those obesity-linked cases compared to 220,000 among men. Postmenopausal breast cancer is the most common obesity-associated cancer in women, while colorectal cancer holds that spot for men. More than 90% of these cases occur in people over 50, but with obesity rates rising in younger adults and even children, the downstream cancer effects are expected to keep climbing.
The connection isn’t just about carrying extra weight. Fat tissue is metabolically active. It produces higher levels of hormones like estrogen and insulin, creates chronic low-grade inflammation throughout the body, and alters the signaling pathways that control cell growth. All of these changes create conditions where cancerous cells are more likely to develop and thrive.
Ultra-Processed Food and Cancer Risk
A large study using data from the UK Biobank found that people who ate the most ultra-processed food had a 7% higher overall cancer risk compared to those who ate the least. For specific cancers, the numbers were more striking: 25% higher risk for lung cancer, 52% higher for brain cancer, and 19% higher ovarian cancer risk for every 10 percentage point increase in ultra-processed food as a share of total diet.
Ultra-processed foods include things like packaged snacks, sugary drinks, instant noodles, reconstituted meat products, and most fast food. These foods tend to be high in sugar, unhealthy fats, salt, and chemical additives while being low in fiber and nutrients. They also make up a growing share of diets in high-income countries, particularly among younger generations. In the U.S., ultra-processed foods now represent more than half of the average person’s calorie intake.
What’s Happening in the Gut
One of the more compelling explanations for rising early-onset cancers centers on the gut microbiome, the trillions of bacteria living in your digestive tract. Research consistently shows that people with colorectal cancer have a distinctly different microbial population compared to healthy individuals. Their guts tend to be enriched with bacteria that promote inflammation and produce toxins that directly damage DNA, while the beneficial bacteria that protect the intestinal lining are depleted.
Some of these harmful bacteria have specific mechanisms that drive cancer development. Certain strains produce a toxin called colibactin that physically crosslinks DNA strands, creating the kind of mutations found in early-onset colorectal tumors. Other species activate inflammatory cascades or suppress immune cells that would normally destroy abnormal cells before they become tumors. Meanwhile, the loss of beneficial bacteria means fewer protective compounds like short-chain fatty acids, which help maintain the gut’s barrier function and keep the immune system in balance.
Western-style diets high in red meat, sugar, and processed food appear to worsen this imbalance by favoring bacteria that produce hydrogen sulfide, a compound implicated in DNA damage. This creates a feedback loop: poor diet disrupts the microbiome, the disrupted microbiome creates a more cancer-friendly environment in the colon, and that environment allows precancerous cells to survive and grow.
Environmental Chemicals Are Accumulating
People alive today carry a higher body burden of synthetic chemicals than any previous generation. Microplastics, now found in human blood, placentas, and lung tissue, act as carriers for a range of hazardous substances. They absorb and release heavy metals like cadmium, flame retardants, PFAS (the “forever chemicals” found in nonstick cookware and water-resistant fabrics), and compounds like bisphenols and phthalates from plastic packaging.
Many of these chemicals are endocrine disruptors, meaning they mimic or interfere with hormones at very low concentrations. Some act like estrogen in the body, which is particularly relevant for hormone-sensitive cancers like breast and uterine cancer. The concern isn’t necessarily that any single chemical causes cancer on its own at typical exposure levels, but that decades of low-level exposure to dozens of these compounds simultaneously may be shifting the odds in ways that are difficult to measure in traditional studies.
Better Detection Plays a Role Too
Not all of the increase represents more people actually developing cancer. Some of it reflects the fact that we’re better at finding it. Advanced imaging, widespread screening programs, and more sensitive blood tests catch cancers that might have gone undiagnosed in earlier decades, particularly slow-growing thyroid and prostate cancers that may never have caused symptoms. The 3% annual rise in prostate cancer diagnoses after 2014, for example, coincided with shifts in screening recommendations that led more men to get tested again after a period of reduced screening.
The COVID-19 pandemic also created a diagnostic backlog. Millions of people skipped routine screenings during 2020 and 2021, and many of those delayed diagnoses showed up in 2022 and 2023 statistics. This made it look like cancer cases surged in a single year when in reality some of those cases had been developing undetected during lockdowns.
Why All of This Is Happening at Once
The WHO identifies tobacco, alcohol, obesity, and air pollution as the primary drivers of rising global cancer rates. But the early-onset trend specifically points to exposures that have changed dramatically since the 1950s and 1960s: the shift toward ultra-processed diets, rising obesity rates in children and young adults, increasing chemical contamination of food and water, more sedentary lifestyles, and the widespread use of antibiotics that alter the gut microbiome from an early age.
People born in later decades appear to carry higher cancer risk than those born earlier, even at the same age. This “birth cohort effect” suggests that something about growing up in the modern environment, likely a combination of many factors rather than one cause, is accelerating the biological clock on cancer development. The cancers rising fastest in young people (colorectal, breast, kidney, pancreatic) are precisely the ones most strongly linked to metabolic health, diet, and hormonal disruption, which reinforces the idea that lifestyle and environmental shifts are the primary culprits.